Kash Purohit

Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study

Boon Chua, Emma Link, Ian Kunkler et al. · The Lancet · 2022 · 107 citations · Full text

Medicine, Oncology, Radiation Oncology +17

International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast

Ivo A. Olivotto, Emma Link, Claire Phillips et al. · Radiotherapy and Oncology · 2019 · 12 citations · Full text

Medicine, Oncology, Surgery +16

A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results

Matthew Winter, Rob Coleman, Jessica Kendall et al. · Journal of bone oncology · 2022 · 10 citations · Full text

Medicine, Oncology, Pharmacology +17